Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor

被引:61
作者
Chung, RT [1 ]
Feng, S
Delmonico, FL
机构
[1] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Surg, Transplant Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] New England Organ Bank Inc, Boston, MA 02114 USA
关键词
donor; HBV; heart; kidney; liver; transplantation;
D O I
10.1034/j.1600-6143.2001.10214.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hepatitis B virus (HBV) is a highly infectious blood-borne pathogen that can be transmitted by a solid organ allograft and result in substantial morbidity and mortality. Recent advances in the management of HBV infection prompt a reappraisal of the approach to the management of allograft recipients from cadaver donors previously exposed to HBV, because of the ongoing shortage of organ donors. This report reviews current knowledge regarding the risk of HBV transmission by an organ from cadaver donors testing positive for markers of HBV infection and makes recommendations for the evaluation, treatment, and surveillance of the allograft recipients.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 33 条
[1]   Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases [J].
Cabrerizo, M ;
Bartolomé, J ;
Caramelo, C ;
Barril, G ;
Carreño, V .
HEPATOLOGY, 2000, 32 (01) :116-123
[2]   THE IMPACT OF DONOR AND RECIPIENT HEPATITIS-B SURFACE-ANTIGEN STATUS ON LIVER-DISEASE AND SURVIVAL IN RENAL-TRANSPLANT RECIPIENTS [J].
CHAN, PCK ;
LOK, ASF ;
CHENG, IKP ;
CHAN, MK .
TRANSPLANTATION, 1992, 53 (01) :128-131
[3]   OCCULT HEPATITIS-B VIRUS AS SOURCE OF INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].
CHAZOUILLERES, O ;
MAMISH, D ;
KIM, M ;
CAREY, K ;
FERRELL, L ;
ROBERTS, JP ;
ASCHER, NL ;
WRIGHT, TL .
LANCET, 1994, 343 (8890) :142-146
[4]   Organ donor screening for infectious diseases - Review of practice and implications for transplantation [J].
Delmonico, FL ;
Snydman, DR .
TRANSPLANTATION, 1998, 65 (05) :603-610
[5]   Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen [J].
Dickson, RC ;
Everhart, JE ;
Lake, JR ;
Wei, YL ;
Seaberg, EC ;
Wiesner, RH ;
Zetterman, RK ;
Pruett, TL ;
Ishitani, MB ;
Hoofnagle, JH ;
Detre, KM ;
Demetris, AJ ;
Lombardero, M ;
Seaberg, E ;
Lawlor, S ;
Fitzgerald, S ;
Haber, J ;
Swanson, GL ;
Wiesner, R ;
Krom, R ;
Porayko, MK ;
Schwerman, L ;
Groettum, C ;
Shaw, B ;
Taylor, K ;
Ascher, N ;
Lake, J ;
BremerKamp, C ;
Everhart, J ;
Shores, S ;
Broccoli, A ;
Hausman, G ;
Shepard, B ;
Carrol, N ;
McGory, R ;
Stevenson, WC ;
McCullough, C ;
Caldwell, S .
GASTROENTEROLOGY, 1997, 113 (05) :1668-1674
[6]   Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation [J].
Dodson, SF ;
de Vera, ME ;
Bonham, CA ;
Geller, DA ;
Rakela, J ;
Fung, JJ .
LIVER TRANSPLANTATION, 2000, 6 (04) :434-439
[7]   Infectivity of hepatic allografts with antibodies to hepatitis B virus [J].
Dodson, SF ;
Issa, S ;
Araya, V ;
Gayowski, T ;
Pinna, A ;
Eghtesad, B ;
Iwatsuki, S ;
Montalvo, E ;
Rakela, J ;
Fung, JJ .
TRANSPLANTATION, 1997, 64 (11) :1582-1584
[8]   Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors [J].
Dodson, SF ;
Bonham, CA ;
Geller, DA ;
Cacciarelli, TV ;
Rakela, J ;
Fung, JJ .
TRANSPLANTATION, 1999, 68 (07) :1058-1061
[9]  
DOUGLAS DD, 1992, HEPATOLOGY, V16, pA49
[10]   PERSISTENCE OF HEPATITIS-B VIRUS-DNA IN THE LIVER AFTER LOSS OF HBSAG IN CHRONIC HEPATITIS-B [J].
FONG, TL ;
DIBISCEGLIE, AM ;
GERBER, MA ;
WAGGONER, JG ;
HOOFNAGLE, JH .
HEPATOLOGY, 1993, 18 (06) :1313-1318